American society of clinical oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer (vol 21, pg 4042, 2003)

被引：0
|
作者：
Hillner
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 07期
关键词：
D O I：
10.1200/JCO.2004.01.990
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1351 / 1351
页数：1
相关论文
共 50 条
  • [41] Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
    Burstein, Harold J.
    Temin, Sarah
    Anderson, Holly
    Buchholz, Thomas A.
    Davidson, Nancy E.
    Gelmon, Karen E.
    Giordano, Sharon H.
    Hudis, Clifford A.
    Rowden, Diana
    Solky, Alexander J.
    Stearns, Vered
    Winer, Eric P.
    Griggs, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (21) : 2255 - +
  • [42] American Society of Clinical Oncology 2011 Annual Meeting Update: Summary of Selected Gynecologic Cancer Abstracts (vol 122, pg 209, 2011)
    Tewari, Krishnansu S.
    Monk, Bradley J.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 451 - 451
  • [43] Role of Bone-Modifying Agents in Multiple Myeloma: American Society of Clinical Oncology Clinical Practice Guideline Update Summary
    Anderson, Kenneth
    Ismaila, Nofisat
    Kyle, Robert A.
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (04) : 266 - +
  • [44] Breast cancer and hormone-replacement therapy in the million women study (vol 362, pg 419, 2003)
    LANCET, 2003, 362 (9390): : 1160 - 1160
  • [45] Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline (vol 31, pg 2942, 2013)
    Rawstron
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4383 - 4383
  • [46] Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression
    Burstein, Harold J.
    Lacchetti, Christina
    Anderson, Holly
    Buchholz, Thomas A.
    Davidson, Nancy E.
    Gelmon, Karen E.
    Giordano, Sharon H.
    Hudis, Clifford A.
    Solky, Alexander J.
    Stearns, Vered
    Winer, Eric P.
    Griggs, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) : 1689 - U250
  • [47] 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology
    Bast, RC
    Ravdin, P
    Hayes, DF
    Bates, S
    Fritsche, H
    Jessup, JM
    Kemeny, N
    Locker, GY
    Mennel, RG
    Somerfield, MR
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) : 1865 - 1878
  • [48] American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction (vol 115, pg 132, 2009)
    Visvanathan, Kala
    Lippman, Scott M.
    Hurley, Patricia
    Temin, Sarah
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 592 - 592
  • [49] American Society of Clinical Oncology recommendations on fertility preservation in cancer patients (vol 24, pg 4963, 2006)
    不详
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (36) : 5790 - 5790
  • [50] Inconsistent criteria used in American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer
    Cardoso, Fatima
    Saghatchian, Mahasti
    Thompson, Alastair
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) : 2058 - 2059
12345